these are subject to price control by the
National Pharmaceutical Pricing Authority (NPPA). Further, exit from these
markets is cumbersome and requires approval ... NPPA. Out of the above said
forty nine relevant markets, formulations based on four molecules are covered under
NLEM. The detailed assessment of these four
allegations made in the complaint.
17.9.6 AIOCD has submitted that NPPA regulates the fixation and revision of prices
of bulk drugs and formulations and also ... AIOCD, till date no complaint has been made before the NPPA for any
violation of the DPCO.
17.9.7 AIOCD has submitted that the practice
Knee Implants (whose prices were fixed
by National Pharmaceutical Pricing Authority ('NPPA') in 2017 and
2018) and Hip Implants as well ... ensure their
affordability. The implementation of DPCO 2013 is overseen by the NPPA. Prices of
such drugs are merely monitored by the NPPA
Knee Implants (whose prices were fixed
by National Pharmaceutical Pricing Authority ('NPPA') in 2017 and
2018) and Hip Implants as well ... ensure their
affordability. The implementation of DPCO 2013 is overseen by the NPPA. Prices of
such drugs are merely monitored by the NPPA
Knee Implants (whose prices were fixed
by National Pharmaceutical Pricing Authority ('NPPA') in 2017 and
2018) and Hip Implants as well ... ensure their
affordability. The implementation of DPCO 2013 is overseen by the NPPA. Prices of
such drugs are merely monitored by the NPPA
Knee Implants (whose prices were fixed
by National Pharmaceutical Pricing Authority ('NPPA') in 2017 and
2018) and Hip Implants as well ... ensure their
affordability. The implementation of DPCO 2013 is overseen by the NPPA. Prices of
such drugs are merely monitored by the NPPA
Knee Implants (whose prices were fixed
by National Pharmaceutical Pricing Authority ('NPPA') in 2017 and
2018) and Hip Implants as well ... ensure their
affordability. The implementation of DPCO 2013 is overseen by the NPPA. Prices of
such drugs are merely monitored by the NPPA
Knee Implants (whose prices were fixed
by National Pharmaceutical Pricing Authority ('NPPA') in 2017 and
2018) and Hip Implants as well ... ensure their
affordability. The implementation of DPCO 2013 is overseen by the NPPA. Prices of
such drugs are merely monitored by the NPPA
Knee Implants (whose prices were fixed
by National Pharmaceutical Pricing Authority ('NPPA') in 2017 and
2018) and Hip Implants as well ... ensure their
affordability. The implementation of DPCO 2013 is overseen by the NPPA. Prices of
such drugs are merely monitored by the NPPA
Knee Implants (whose prices were fixed
by National Pharmaceutical Pricing Authority ('NPPA') in 2017 and
2018) and Hip Implants as well ... ensure their
affordability. The implementation of DPCO 2013 is overseen by the NPPA. Prices of
such drugs are merely monitored by the NPPA
